470 related articles for article (PubMed ID: 36674486)
1. Similar Pro- and Antiangiogenic Profiles Close to Delivery in Different Clinical Presentations of Two Pregnancy Syndromes: Preeclampsia and Fetal Growth Restriction.
Dymara-Konopka W; Laskowska M; Grywalska E; Hymos A; Błażewicz A; Leszczyńska-Gorzelak B
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674486
[TBL] [Abstract][Full Text] [Related]
2. Soluble endoglin versus sFlt-1/PlGF ratio: detection of preeclampsia, HELLP syndrome, and FGR in a high-risk cohort.
Iannaccone A; Reisch B; Mavarani L; Darkwah Oppong M; Kimmig R; Mach P; Schmidt B; Köninger A; Gellhaus A
Hypertens Pregnancy; 2022; 41(3-4):159-172. PubMed ID: 35475405
[TBL] [Abstract][Full Text] [Related]
3. Urinary placental growth factor in preeclampsia and fetal growth restriction: An alternative to circulating biomarkers?
Zhang K; Zen M; Popovic NL; Lee VW; Alahakoon TI
J Obstet Gynaecol Res; 2019 Sep; 45(9):1828-1836. PubMed ID: 31257726
[TBL] [Abstract][Full Text] [Related]
4. Levels of serum-circulating angiogenic factors within 1 week prior to delivery are closely related to conditions of pregnant women with pre-eclampsia, gestational hypertension, and/or fetal growth restriction.
Nanjo S; Minami S; Mizoguchi M; Yamamoto M; Yahata T; Toujima S; Shiro M; Kobayashi A; Muragaki Y; Ino K
J Obstet Gynaecol Res; 2017 Dec; 43(12):1805-1814. PubMed ID: 28929598
[TBL] [Abstract][Full Text] [Related]
5. Soluble fms-like tyrosine kinase to placental growth factor ratio in different stages of early-onset fetal growth restriction and small for gestational age.
Garcia-Manau P; Mendoza M; Bonacina E; Garrido-Gimenez C; Fernandez-Oliva A; Zanini J; Catalan M; Tur H; Serrano B; Carreras E
Acta Obstet Gynecol Scand; 2021 Jan; 100(1):119-128. PubMed ID: 32860218
[TBL] [Abstract][Full Text] [Related]
6. Placental productions and expressions of soluble endoglin, soluble fms-like tyrosine kinase receptor-1, and placental growth factor in normal and preeclamptic pregnancies.
Gu Y; Lewis DF; Wang Y
J Clin Endocrinol Metab; 2008 Jan; 93(1):260-6. PubMed ID: 17956952
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal change of sFlt-1/PlGF ratio in singleton pregnancy with early-onset fetal growth restriction.
Herraiz I; Quezada MS; Rodriguez-Calvo J; Gómez-Montes E; Villalaín C; Galindo A
Ultrasound Obstet Gynecol; 2018 Nov; 52(5):631-638. PubMed ID: 28876491
[TBL] [Abstract][Full Text] [Related]
8. Discordant clinical presentations of preeclampsia and intrauterine fetal growth restriction with similar pro- and anti-angiogenic profiles.
Alahakoon TI; Zhang W; Trudinger BJ; Lee VW
J Matern Fetal Neonatal Med; 2014 Dec; 27(18):1854-9. PubMed ID: 24397483
[TBL] [Abstract][Full Text] [Related]
9. Correlation of Kryptor and Elecsys® immunoassay sFlt-1/PlGF ratio on early diagnosis of preeclampsia and fetal growth restriction: A case-control study.
Simón E; Herraiz I; Villalaín C; Gómez-Arriaga PI; Quezada MS; López-Jiménez EA; Galindo A
Pregnancy Hypertens; 2020 Apr; 20():44-49. PubMed ID: 32172169
[TBL] [Abstract][Full Text] [Related]
10. sFlt-1 to PlGF ratio cut-offs to predict adverse pregnancy outcomes in early-onset FGR and SGA: a prospective observational study.
Bonacina E; Armengol-Alsina M; Hurtado I; Garcia-Manau P; Ferrer-Oliveras R; Monreal S; Pancorbo M; Mendoza M; Carreras E
J Obstet Gynaecol; 2022 Oct; 42(7):2840-2845. PubMed ID: 35980876
[TBL] [Abstract][Full Text] [Related]
11. Predictive value of angiogenic factors, clinical risk factors and uterine artery Doppler for pre-eclampsia and fetal growth restriction in second and third trimester pregnancies in an Ecuadorian population.
Kienast C; Moya W; Rodriguez O; Jijón A; Geipel A
J Matern Fetal Neonatal Med; 2016; 29(4):537-43. PubMed ID: 25708492
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of angiogenic markers in pregnancy with fetal growth restriction.
Palmrich P; Kalafat E; Pateisky P; Schirwani-Hartl N; Haberl C; Herrmann C; Khalil A; Binder J
Ultrasound Obstet Gynecol; 2024 May; 63(5):619-626. PubMed ID: 37774098
[TBL] [Abstract][Full Text] [Related]
13. The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia.
Aggarwal PK; Chandel N; Jain V; Jha V
J Hum Hypertens; 2012 Apr; 26(4):236-41. PubMed ID: 21451568
[TBL] [Abstract][Full Text] [Related]
14. Clinical utility of sFlt-1 and PlGF in screening, prediction, diagnosis and monitoring of pre-eclampsia and fetal growth restriction.
Stepan H; Galindo A; Hund M; Schlembach D; Sillman J; Surbek D; Vatish M
Ultrasound Obstet Gynecol; 2023 Feb; 61(2):168-180. PubMed ID: 35816445
[TBL] [Abstract][Full Text] [Related]
15. Correlation between placental weight and angiogenic markers sFlt-1 and PlGF in women with preeclampsia and fetal growth restriction.
Lorenz-Meyer LA; Frank L; Sroka D; Busjahn A; Henrich W; Verlohren S
Pregnancy Hypertens; 2022 Jun; 28():149-155. PubMed ID: 35453103
[TBL] [Abstract][Full Text] [Related]
16. Clinical implementation of the sFlt-1/PlGF ratio to identify preeclampsia and fetal growth restriction: A prospective cohort study.
Herraiz I; Simón E; Gómez-Arriaga PI; Quezada MS; García-Burguillo A; López-Jiménez EA; Galindo A
Pregnancy Hypertens; 2018 Jul; 13():279-285. PubMed ID: 30177066
[TBL] [Abstract][Full Text] [Related]
17. The predictive value of the sFlt-1/PlGF ratio on short-term absence of preeclampsia and maternal and fetal or neonatal complications in twin pregnancies.
Saleh L; Tahitu SIM; Danser AHJ; van den Meiracker AH; Visser W
Pregnancy Hypertens; 2018 Oct; 14():222-227. PubMed ID: 29678353
[TBL] [Abstract][Full Text] [Related]
18. Novel circulating placental markers prokineticin-1, soluble fms-like tyrosine kinase-1, soluble endoglin and placental growth factor and association with late miscarriage.
Jayasena CN; Abbara A; Comninos AN; Narayanaswamy S; Gonzalez Maffe J; Izzi-Engbeaya C; Oldham J; Lee TT; Sarang Z; Malik Z; Dhanjal MK; Williamson C; Regan L; Bloom SR; Dhillo WS
Hum Reprod; 2016 Dec; 31(12):2681-2688. PubMed ID: 27664209
[TBL] [Abstract][Full Text] [Related]
19. Prediction of preterm birth in growth-restricted and appropriate-for-gestational-age infants using maternal PlGF and the sFlt-1/PlGF ratio-A prospective study.
Hong J; Crawford K; Cavanagh E; da Silva Costa F; Kumar S
BJOG; 2024 Jul; 131(8):1089-1101. PubMed ID: 38196326
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the soluble fms-like tyrosine kinase-1 to placental growth factor ratio in pregnancies complicated by fetal growth restriction.
Herraiz I; Dröge LA; Gómez-Montes E; Henrich W; Galindo A; Verlohren S
Obstet Gynecol; 2014 Aug; 124(2 Pt 1):265-273. PubMed ID: 25004342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
